Environment
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
StateMarylandTo Governor
HB 1470: Medical Assistance Programs - Drug Dispensing - Cost-of-Dispensing Survey
Bonnie Cullison
HB 1470 status: To Governor — Approved by the Governor - Chapter 709 (updated May 26, 2026).
Source
OpenStates
Confidence
Low
Analysis basis
OpenStates summary
01
What this bill does
Official summary alongside an AI-generated read on where it stands and why.
Overall Score
80OUT OF 100
Score:80/100 civic fit
Risk:Low Risk
Impact:Moderate Impact 50/100
Constitutionality100%
Bipartisan70%
Public opinion85%
Bill summary
This bill is about how much the government pays pharmacies to fill prescriptions for people on state health programs. Lawmakers want to do a study to see what it *actually* costs pharmacies to give out medicine so they can make sure the payment is fair. The bill is currently being discussed by lawmakers in the House.
02
Impact analysis
✦ AI analysisModeled effects across six domains, estimated from bill text and comparable legislation.
Economy
Positive outlook
75%
Benefits
- Aligns government reimbursement with actual pharmacy costs
- Improves fairness in state Medicaid vendor compensation
- Provides empirical data for future legislative budget decisions
Risks
- Incurs administrative costs for state government study execution
- Imposes data reporting burdens on surveyed pharmacies
- Potential for survey results to be influenced by industry interests
Society
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
Technology Industry
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
Civic Accountability
Positive outlook
85%
Benefits
- Requires objective data for state expenditure justifications
- Mandates transparency in the drug-dispensing payment process
- Establishes a factual basis for regulatory oversight
Risks
- Limited scope of the report to a single survey instance
- Implementation timeline may delay necessary rate adjustments
- Lack of mechanism to mandate action based on study findings
Public Health & Safety
Positive outlook
80%
Benefits
- Protects beneficiary access to essential prescription medications
- Reduces risks of pharmacy closures serving vulnerable populations
- Ensures consistent dispensing services for Medical Assistance recipients
Risks
- Possible transitional service disruptions during policy reviews
- Risk that survey results fail to capture all patient care needs
- Potential for rate-setting to lag behind market inflation
03
How trustworthy & consequential it is
Sourcing already shown above, this is what the analysis found worth flagging.
Source
OpenStates
Official bill text or data from OpenStates.
Confidence
Low
Information is limited or incomplete.
Analysis basis
OpenStates summary
Source used for this bill's analysis.
Source note
LegiScan returned a PDF-only document. PDF extraction is not enabled in this build, so the pipeline used a safer fallback.
Analysis scope
Analysis based on abstract metadata and summary only; full text not provided.
04
Where it stands
Official record- IntroducedComplete
- CommitteeComplete
- Chamber votesComplete
- Final agreementComplete
- GovernorCurrent
- EnactedUpcoming
05
How it affects your district
✦ Personalized
Set your location
Add your district to see how this bill may affect your community and who to contact.
Your Representatives
Your representatives appear here once you add your location.
06
Take action
Contact your representatives
Let them know how you feel about this bill.
Share your view
Join the discussion and see what others are saying.
Track this bill
Stay updated on progress and changes.